Diabetes: Spotlight on Stem Cell Research – Ed Baetge

Posted: Published on September 23rd, 2011

This post was added by Dr. Richardson



(Part 3 of 4) Ed Baetge, Ph.D. spoke at the Spotlight on Juvenile Diabetes, an educational event presented at the CIRM Governing Board meeting on September 25, 2008. Baetge discussed Novocell, Inc.'s (now ViaCyte) efforts to generate replacement pancreatic beta islet cells from human embryonic stem cells for the development of cell-based diabetes therapies

Excerpt from:
Diabetes: Spotlight on Stem Cell Research - Ed Baetge

Related Posts
This entry was posted in Stem Cell Human Trials. Bookmark the permalink.

Comments are closed.